Approval · Notice of Compliance 2190 · 2001
DIAZEPAM AUTOINJECTOR: Notice of Compliance 2190
Issued January 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2190
- Date
- January 22, 2001
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Anxiolytic - sedative
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIAZEPAM AUTOINJECTOR | 02243240 | Cancelled Post Market |
Medicinal ingredients
- DIAZEPAM 5 MG per ML